KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Elevance Health (ELV) Net Cash Flow (2016 - 2025)

Elevance Health (ELV) has disclosed Net Cash Flow for 17 consecutive years, with $548.0 million as the latest value for Q4 2025.

  • On a quarterly basis, Net Cash Flow rose 15.13% to $548.0 million in Q4 2025 year-over-year; TTM through Dec 2025 was $972.0 million, a 47.0% decrease, with the full-year FY2025 number at $2.9 billion, up 60.63% from a year prior.
  • Net Cash Flow was $548.0 million for Q4 2025 at Elevance Health, up from $154.0 million in the prior quarter.
  • In the past five years, Net Cash Flow ranged from a high of $3.6 billion in Q1 2021 to a low of -$4.4 billion in Q4 2023.
  • A 5-year average of $180.8 million and a median of $299.0 million in 2022 define the central range for Net Cash Flow.
  • Peak YoY movement for Net Cash Flow: plummeted 696.48% in 2021, then skyrocketed 935.04% in 2022.
  • Elevance Health's Net Cash Flow stood at -$609.0 million in 2021, then tumbled by 144.17% to -$1.5 billion in 2022, then crashed by 195.49% to -$4.4 billion in 2023, then surged by 110.83% to $476.0 million in 2024, then increased by 15.13% to $548.0 million in 2025.
  • Per Business Quant, the three most recent readings for ELV's Net Cash Flow are $548.0 million (Q4 2025), $154.0 million (Q3 2025), and $1.1 billion (Q2 2025).